about
Radiotherapy combination opportunities leveraging immunity for the next oncology practiceChallenges of Using High-Dose Fractionation Radiotherapy in Combination TherapyModern Radiotherapy Concepts and the Impact of Radiation on Immune ActivationPD-1/PD-L1 blockades in non-small-cell lung cancer therapyThe potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapyRadiation for Awakening the Dormant Immune System, a Promising Challenge to be ExploredThe effect of radiation on the immune response to cancersUnlocking the combination: potentiation of radiation-induced antitumor responses with immunotherapyRadiation meets immunotherapy - a perfect match in the era of combination therapy?Combining radiotherapy and cancer immunotherapy: a paradigm shiftRadiotherapy and the tumor stroma: the importance of dose and fractionationCancer vaccinesRadiation-induced immune responses: mechanisms and therapeutic perspectivesCancer immunotherapy: how low-level ionizing radiation can play a key role.Radiation-induced modulation of costimulatory and coinhibitory T-cell signaling molecules on human prostate carcinoma cells promotes productive antitumor immune interactionsImmunotherapy and radiation therapy for malignant pleural mesothelioma.Gene and miRNA expression profiles of mouse Lewis lung carcinoma LLC1 cells following single or fractionated dose irradiation.News Feature: Radiation reduxHypofractionated stereotactic radiation therapy activates the peripheral immune response in operable stage I non-small-cell lung cancer.Differential expression of stress and immune response pathway transcripts and miRNAs in normal human endothelial cells subjected to fractionated or single-dose radiation.Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation.Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer.Defining molecular signature of pro-immunogenic radiotherapy targets in human prostate cancer cells.Combinations of immunotherapy and radiation in cancer therapy.Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor AntigenCancer-associated fibroblasts from lung tumors maintain their immunosuppressive abilities after high-dose irradiation.Quantitative proteomic analysis of single or fractionated radiation-induced proteins in human breast cancer MDA-MB-231 cellsRadiation takes its TollIn the field: exploiting the untapped potential of immunogenic modulation by radiation in combination with immunotherapy for the treatment of cancer.Radiation as an immunological adjuvant: current evidence on dose and fractionation.A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)Cytokines in radiobiological responses: a review.Opportunities for Radiosensitization in the Stereotactic Body Radiation Therapy (SBRT) EraAddressing the Symptoms or Fixing the Problem? Developing Countermeasures against Normal Tissue Radiation Injury.Radiation therapy generates platelet-activating factor agonistsThe intersection of radiotherapy and immunotherapy: mechanisms and clinical implications.Radiotherapy and MVA-MUC1-IL-2 vaccine act synergistically for inducing specific immunity to MUC-1 tumor antigen.Integrating conventional and antibody-based targeted anticancer treatment into immunotherapyA phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response.Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C.
P2860
Q26738443-E2AD2B25-6959-4508-A878-3E61163BA9BEQ26742107-CC6D6630-7568-4EF3-823A-A1DE5315B847Q26744490-B83CF990-3BF0-49BA-A05B-5ADB820281EFQ26765024-9BB0C28D-366C-48D5-93D4-C076231EDAD6Q26783291-DC8D3856-09E2-4133-AC97-5CB272D66FDEQ26865395-C028BC78-7C57-4E29-8F1D-BFF6E4C791DEQ26995372-FA1435C6-8549-42BF-B796-DDE6C73ECFEDQ27001216-B0A62103-CDD2-4A2C-81C5-FBFA3A19D2EDQ27005913-74017F6D-EB28-46FE-8413-FEED4DC01443Q27021428-FC042A5D-7847-4438-ABA3-204E8D7BC121Q27022685-32B73C09-AF4B-4250-AC3F-A8312581B898Q27024438-EDDA5AC5-CDC5-4955-9F68-53A3DE3FD381Q28080006-9D3223CD-BD75-4081-AEB3-47D08B052898Q30235014-518D6B24-611E-444C-9504-FBCF70E12246Q33627023-C3EB55EE-3852-4EF7-925C-23020BB33BFEQ33645613-1C73E010-D330-45E0-9E87-01576525258DQ33751085-F8BA74A7-ABC9-47AF-BB15-5E6949B42F26Q33847819-E511A53D-733F-492B-8687-28A4FDB9A39FQ33884923-0D31ECE3-FE79-4771-B6CC-41122E6C3008Q33911452-2735E819-E217-486B-B552-EE095C291E38Q34032559-DFD4DCE1-EF6B-41D1-A9C2-1CF1B6601309Q34333155-D112F936-B985-4E94-AE2E-020CB878B8F7Q34438000-494797EC-BF14-43FF-8BBD-A3A3012E8997Q34582640-76AF65DE-689B-4217-9603-689BA110FF99Q35328111-3165C165-3905-4F48-BA46-1A86D491E9C0Q35598951-C8B87D4B-11B6-4BBB-B894-CFFAF399B484Q35693267-78FC2C33-80DC-4534-9D82-DD489D4477EFQ36083353-2675D1DF-4DBE-42C7-B8E5-40CAE0019644Q36210670-C3C3D99D-4582-4D3E-BF32-ACB63D9E3303Q36347177-CD0B4EB5-EB58-4575-B2DE-768A5B89DF4EQ36651935-60611FE4-A3BC-48A0-99B3-88F40653CD30Q37045283-476E1DBF-1B90-427E-9E0E-21346A123640Q37118895-77DCC23B-B978-4EEE-98CF-DA2410EECA19Q37189966-AF352D18-BDBF-45DB-8150-A52222E712DDQ37190440-2F07F6BF-A79D-41B4-A08B-79D6871448D5Q37518395-FA548E33-4F8F-41A6-AB3B-EA32563FB2E1Q37589407-D858D2B7-8987-4A49-B152-250AE5EB0178Q37592814-1D56D4F8-43BC-4F75-BE2A-E55A8AAE3D2FQ37615827-FC63763E-9261-46DA-93D9-D75386CE647EQ37666685-490DAFC3-A1EB-452D-AE8A-9B59B3DA6B48
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Maximizing tumor immunity with fractionated radiation.
@ast
Maximizing tumor immunity with fractionated radiation.
@en
type
label
Maximizing tumor immunity with fractionated radiation.
@ast
Maximizing tumor immunity with fractionated radiation.
@en
prefLabel
Maximizing tumor immunity with fractionated radiation.
@ast
Maximizing tumor immunity with fractionated radiation.
@en
P2093
P2860
P1476
Maximizing tumor immunity with fractionated radiation.
@en
P2093
Dörthe Schaue
Josephine A Ratikan
Keisuke S Iwamoto
William H McBride
P2860
P304
P356
10.1016/J.IJROBP.2011.09.049
P407
P577
2011-12-28T00:00:00Z